Altamira Therapeutics Ltd.: profit_loss
| Value | {"unit": "CHF", "value": -4825018, "concept": "us-gaap:ProfitLoss"} |
|---|---|
| Period | 2018-01-01 – 2018-06-30 |
| Status | current |
| Entity | Altamira Therapeutics Ltd. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:24:22.861909+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/b409ba62-b14c-4169-97e8-bb3a19996e23
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-19-015943Retrieved: 2026-08-19T16:24:22.861909+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001601936/profit-loss/2018-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/b409ba62-b14c-4169-97e8-bb3a19996e23
History
- no predecessors — first report